Article
Cardiac Microvascular Rarefaction in Hyperthyroidism Induced Left Ventricle Dysfunction
Registro en:
FREITAS, Felipe; et al. Cardiac Microvascular Rarefaction in HyperthyroidismInduced Left Ventricle Dysfunction, v.20, n.7, p.590-598, Oct. 2013
1073-9688
10.1111/micc.12057
1549-8719
Autor
Freitas, Felipe
Estato, Vanessa
Carvalho, Vinícius Frias
Torres, Rafael Carvalho
Lessa, Marcos Adriano
Tibiriçá, Eduardo
Resumen
Objective: The pathophysiology underlying hyperthyroidisminduced
left ventricle (LV) dysfunction and hypertrophy directly
involves the heart and indirectly involves the neuroendocrine
systems. The effects of hyperthyroidism on the microcirculation are
still controversial in experimental models. We investigated the
effects of hyperthyroidism on the cardiac function and microcirculation
of an experimental rat model.
Methods: Male Wistar rats (170–250 g) were divided into two
groups: the euthyroid group (n = 10), which was treated with 0.9%
saline solution, and the hyperthyroid group (n = 10), which was
treated with L-thyroxine (600 lg/kg/day, i.p.) during 14 days. An
echocardiographic study was performed to evaluate the alterations in
cardiac function, structure and geometry. The structural capillary
density and the expression of angiotensin II AT1 receptor in the LV
were analyzed using histochemistry and immunohistochemistry,
respectively.
Results: Hyperthyroidism was found to induce profound cardiovascular
alterations, such as systolic hypertension, tachycardia, LV
dysfunction, cardiac hypertrophy, and myocardial fibrosis. This
study demonstrates the existence of structural capillary rarefaction
and the down-regulation of the cardiac angiotensin II AT1 receptor
in the myocardium of hyperthyroid rats in comparison with
euthyroid rats.
Conclusions: Microvascular rarefaction may be involved in the
pathophysiology of hyperthyroidism-induced cardiovascular alterations.